# Use of Hyperpolarized 129Xe MR Lung Imaging in Infants

> **NCT04995562** · PHASE4 · RECRUITING · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 12 (estimated)

## Conditions studied

- Lungs; Developmental Disorder

## Interventions

- **DRUG:** 129Xe

## Key facts

- **NCT ID:** NCT04995562
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-05-06
- **Primary completion:** 2027-05-01
- **Final completion:** 2028-05-01
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04995562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04995562, "Use of Hyperpolarized 129Xe MR Lung Imaging in Infants". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04995562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*